SK Chemicals said on the 3rd that it signed a joint sales contract with Kyungnam Pharm for the allergic rhinitis treatment "Noseal Soft Capsule."
Under the agreement, Kyungnam Pharm will take charge of sales to pharmacies and marketing for Noseal Soft Capsule, which SK Chemicals has been distributing through a pharmaceutical ordering platform.
Noseal Soft Capsule is an over-the-counter (OTC) medicine from SK Chemicals with fexofenadine, a third-generation antihistamine, as the main ingredient, and is used to relieve allergic rhinitis symptoms caused by pollen and house dust. Among OTC antihistamines approved in Korea, it is a product that specifies in its indications and effects the relief of allergic rhinitis symptoms caused by dust triggers such as house dust.
Fexofenadine is known to have a lower incidence of sedative effects such as drowsiness compared with existing antihistamines. Noseal Soft Capsule applies a liquid-filled soft capsule formulation for absorption characteristics in the body, and, according to the company, places relatively less burden on the liver, allowing use while taking other medications in line with medical professional advice.
Kyungnam Pharm has a sales organization consisting of 11 branches nationwide and a broad pharmacy distribution network, and is regarded as competitive in OTC marketing and sales. It operates a diverse pharmacy-focused brand portfolio, including the flagship vitamin C brand "Lemona," as well as tonic stimulants, sore throat treatments, and athlete's foot treatments.
SK Chemicals expects that, through this collaboration, the pharmacy distribution network and field sales capability for Noseal Soft Capsule will be further strengthened.
Park Hyun-seon, head of the pharma business at SK Chemicals, said, "This joint sales effort is a collaboration to build a more efficient supply structure in the rhinitis treatment market by combining pharmacy sales expertise with Noseal Soft Capsule, which has product competitiveness," adding, "Based on the strengths of both companies, we will improve accessibility in pharmacies and expand our presence in the market."